William Mullen
Director/Miembro de la Junta en NeuroTargets Ltd. .
Perfil
William Mullen is a Non-Executive Director of NeuroTargets Ltd.
He was Chief Executive Officer of Progeny bioVentures Limited from 1996 to 1999.
He was Chief Executive Officer of Rowett Research Services Limited.
Dr. Mullen received a BS degree in Biochemistry from the University of Sussex and a PhD in Biochemistry from the University of Bath.
Cargos activos de William Mullen
| Empresas | Cargo | Inicio |
|---|---|---|
NeuroTargets Ltd.
 NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de William Mullen.
| Empresas | Cargo | Fin |
|---|---|---|
Rowett Research Services Ltd.
 Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom. | Presidente | - |
Formación de William Mullen.
| University of Sussex | Undergraduate Degree |
| University of Bath | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Health Technology |
Rowett Research Services Ltd.
Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- William Mullen
